Bridgefront Capital’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,509
Closed -$286K 611
2023
Q2
$286K Buy
+11,509
New +$286K 0.15% 266
2023
Q1
Sell
-44,279
Closed -$524K 591
2022
Q4
$524K Buy
44,279
+24,434
+123% +$289K 0.37% 87
2022
Q3
$117K Buy
+19,845
New +$117K 0.12% 269